Masayo Kojima

Masayo Kojima

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2002 in Psychiatry Research
Verified
Journal Article
Closed access
MKMasayo Kojima
Masayo Kojima
TFToshiaki A Furukawa
Toshiaki A Furukawa
HTHidekatsu Takahashi
Hidekatsu Takahashi
MKMakoto Kawai
Makoto Kawai
TNTeruo Nagaya
Teruo Nagaya
STShinkan Tokudome
Shinkan Tokudome

1 October 1997 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
KWKenji Wakai
Kenji Wakai
ATAkiko Tamakoshi
Akiko Tamakoshi
KIKiyonobu Ikezaki
Kiyonobu Ikezaki
MFMasashi Fukui
Masashi Fukui
TKTakashi Kawamura
Takashi Kawamura
YOYoshiyuki Ohno
Yoshiyuki Ohno

1 January 2000 in Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
MKMasayo Kojima
Masayo Kojima
KWKenji Wakai
Kenji Wakai
TKTakashi Kawamura
Takashi Kawamura
ATAkiko Tamakoshi
Akiko Tamakoshi
RARie Aoki
Rie Aoki
YOYoshiyuki Ohno
Yoshiyuki Ohno
A population-based cohort study was conducted to assess the relationship between total mortality and self-reported sleep patterns as regards not only to sleep duration but also subjective sleep quality. A total of 5, 322 inhabitants in Gifu Prefecture, Japan, completed a selfadministered questionnaire on health status and lifestyles including habitual sleep patterns, and were followed-up for an average of 11.9 years. Relative risks were computed by using Cox proportional hazards models. Both longer and shorter sleep, compared to 7-8 hour-sleep, was related to significantly increased risk of total mortality in males (relative risk [RR] for g"10 hours = 1.94, and RR for <7 hour = 1.90), but not in females. Females complaining of poor awakening state experienced a higher mortality risk compared to those who woke up normally (RR: 1.97). Males who usually fell asleep easily showed a marginally lower mortality risk compared to those who fell asleep normally (RR: 0.70). Female users of sleeping pills were at an elevated risk (RR: 1.89). These findings were almost unchanged after adjustment for sleep duration and other confounders. Poor self-reported quality of sleep seemed to be associated with an increased risk of mortality independently of sleep duration. J Epidemiol, 2000 ; 10 : 87-93

30 July 2009 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
MKMasayo Kojima
Masayo Kojima
TKToshihisa Kojima
Toshihisa Kojima
SSSadao Suzuki
Sadao Suzuki
TOTakeshi Oguchi
Takeshi Oguchi
MOMichinari Oba
Michinari Oba
NINaoki Ishiguro
Naoki Ishiguro
Objective: An association between depression and inflammation has been suggested. In patients with rheumatoid arthritis (RA), pain is a major symptom associated with depression and inflammation. We examined the independent associations between depression, the inflammation marker C‐reactive protein (CRP) level, and pain in patients with RA.Methods: In total, 218 RA outpatients completed self‐administered questionnaires, using the Beck Depression Inventory II to measure depressive symptoms and a visual analog scale to quantify their perceived pain. Functional disability and CRP level were also measured.Results: Depression scores were mildly and positively correlated with the CRP level (r = 0.46, P < 0.001). Both the depression score (standardized β = 0.35, P < 0.001) and the CRP level (standardized β = 0.35, P < 0.001) were significantly associated with pain, even after adjustment for clinical covariates in regression analysis. In logistic analysis, the combined effects on the risk of severe pain (pain score in the upper tertile) increased with depression scores and CRP levels linearly.Conclusion: Depression severity and inflammation were associated with each other and appeared to have independent effects on perceived pain. Therefore, a clinical approach that takes into account both the body and the mind could have benefits and could enable optimal pain control.

1 June 2005 in Psychiatry Research
Verified
Journal Article
Closed access
THTakahiro Hiroe
Takahiro Hiroe
MKMasayo Kojima
Masayo Kojima
IYIkuyo Yamamoto
Ikuyo Yamamoto
SNSuguru Nojima
Suguru Nojima
YKYoshihiro Kinoshita
Yoshihiro Kinoshita
TFToshi A. Furukawa
Toshi A. Furukawa

5 July 2006 in Nephrology Dialysis Transplantation
Verified
Journal Article
Open access
PDF file
KWKenji Wakai
Kenji Wakai
TKTakashi Kawamura
Takashi Kawamura
MEMasayuki Endoh
Masayuki Endoh
MKMasayo Kojima
Masayo Kojima
YTYasuhiko Tomino
Yasuhiko Tomino
HSHideto Sakai
Hideto Sakai
Background. Immunoglobulin A (IgA) nephropathy is the most common form of glomerulonephritis in the world, and a substantial number of patients develop end-stage renal disease (ESRD). Although there are several prognostic indicators, it remains difficult to predict the renal outcome in individual patients. Methods. A prospective cohort study was conducted in 97 clinical units in Japan from 1995 to 2002. We analysed the data from 2269 patients using proportional hazards models in order to determine the predictors of ESRD in IgA nephropathy and to develop a scoring system to estimate ESRD risk. Results. During the follow-up (median, 77 months), 207 patients developed ESRD. Systolic hypertension, proteinuria, hypoproteinaemia, azotaemia and a high histological grade at initial renal biopsy were independently associated with the risk of ESRD. Mild haematuria predisposed patients to ESRD more than severe haematuria. A scoring system was developed to estimate the 7-year ESRD risk from eight clinical and pathological variables. Actually, this prognostic score accurately classified patients by risk: patients with estimates of 0.0–0.9, 1.0–4.9, 5.0–19.9, 20.0–49.9, and 50.0–100.0% had a 0.2, 2.4, 12.2, 40.2 and 80.8% of ESRD incidence over 7 years, respectively. The corresponding area under the receiver operating characteristic curve was 0.939 [95% confidence interval (CI), 0.921–0.958]. This score was verified in repetitions of the derivation-validation technique. Conclusions. Although the quality of some data collected by the mail survey is limited and the influence of therapy could not be considered, this scoring system will serve as a useful prognostic tool for IgA nephropathy in clinical practice.